Post-COVID-19 chest imaging evaluation: which patients should be prioritized for follow-up pulmonary assessment?
Objectives: The current study evaluated the long‑term lung abnormalities based on initial and follow‑up chest computed tomography (CT) images of COVID‑19 patients and investigates the possible factors associated with them. Methods: One hundred and twenty‑four hospitalized COVID‑19 patients who recei...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Kashan University of Medical Sciences
2023-07-01
|
Series: | International Archives of Health Sciences |
Subjects: | |
Online Access: | http://iahsj.kaums.ac.ir/article_176536_5661cb3311046a587b3c3e3d3f6732f4.pdf |
_version_ | 1797680957063430144 |
---|---|
author | Bahareh Safikhani Soheil Rahmani Fard Leyla Bahadorizadeh Fatemeh Shakki Katouli Yousef Alimohamadi Sara Minaeian |
author_facet | Bahareh Safikhani Soheil Rahmani Fard Leyla Bahadorizadeh Fatemeh Shakki Katouli Yousef Alimohamadi Sara Minaeian |
author_sort | Bahareh Safikhani |
collection | DOAJ |
description | Objectives: The current study evaluated the long‑term lung abnormalities based on initial and follow‑up chest computed tomography (CT) images of COVID‑19 patients and investigates the possible factors associated with them.
Methods: One hundred and twenty‑four hospitalized COVID‑19 patients who received a follow‑up chest CT scan in three hospitals in Tehran between February 20, 2021 and September, 2021, were included. Based on the presence of persistent lesions in the follow‑up images, patients were divided into residual and nonresidual groups, and logistic regression analysis was performed to investigate the association between different disease characteristics and long‑term lung abnormalities.
Results: The most frequent abnormality in the initial imaging was ground‑glass opacities which was observed in 95.3% of patients, and residual lesions were observed in 39.8% of patients at the follow‑up date. Patients in the residual group were generally older, more frequently suffered from hypertension and dyspnea, and had lower oxygen saturation and lymphocyte count, and lymphopenia was more prevalent among them. Moreover, patients in the residual group had higher initial lung involvement score, and the presence of lymphadenopathy and consolidation was more frequent among them. After adjustment for age, gender, and intervals between the two imagings, logistic regression results showed that hospitalization period, dyspnea, decreased oxygen saturation, decreased lymphocyte count, lymphopenia, consolidation, lymphadenopathy, and high initial lung involvement were strongly associated with the presence of long‑term abnormalities.
Conclusion: The current study revealed multiple discrepancies between residual and nonresidual groups, which can be used to better identify the patients at risk of long‑term COVID‑19 lung complications. |
first_indexed | 2024-03-11T23:38:21Z |
format | Article |
id | doaj.art-bd31c96b6aa64b9488f9e9bf6ef7e481 |
institution | Directory Open Access Journal |
issn | 2383-2568 |
language | English |
last_indexed | 2024-03-11T23:38:21Z |
publishDate | 2023-07-01 |
publisher | Kashan University of Medical Sciences |
record_format | Article |
series | International Archives of Health Sciences |
spelling | doaj.art-bd31c96b6aa64b9488f9e9bf6ef7e4812023-09-19T17:49:26ZengKashan University of Medical SciencesInternational Archives of Health Sciences2383-25682023-07-01102475210.48307/iahsj.2023.176536176536Post-COVID-19 chest imaging evaluation: which patients should be prioritized for follow-up pulmonary assessment?Bahareh Safikhani0Soheil Rahmani Fard1Leyla Bahadorizadeh2Fatemeh Shakki Katouli3Yousef Alimohamadi4Sara Minaeian5Department of Radiology, Rasool-E-Akram General Hospital, Iran University of Medical sciences, Tehran, IranAntimicrobial Resistance Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, IranAntimicrobial Resistance Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran Department of Internal Medicine, Rasool-E-Akram General Hospital, Iran University of Medical Sciences, Tehran, IranDepartment of Radiology, Arash Women General Hospital, Tehran University of Medical Sciences, Tehran, IranPars Advanced and Minimally Invasive Medical Manners Research Center, Pars Hospital, Iran University of Medical Sciences, Tehran, IranPars Advanced and Minimally Invasive Medical Manners Research Center, Pars Hospital, Iran University of Medical Sciences, Tehran, IranObjectives: The current study evaluated the long‑term lung abnormalities based on initial and follow‑up chest computed tomography (CT) images of COVID‑19 patients and investigates the possible factors associated with them. Methods: One hundred and twenty‑four hospitalized COVID‑19 patients who received a follow‑up chest CT scan in three hospitals in Tehran between February 20, 2021 and September, 2021, were included. Based on the presence of persistent lesions in the follow‑up images, patients were divided into residual and nonresidual groups, and logistic regression analysis was performed to investigate the association between different disease characteristics and long‑term lung abnormalities. Results: The most frequent abnormality in the initial imaging was ground‑glass opacities which was observed in 95.3% of patients, and residual lesions were observed in 39.8% of patients at the follow‑up date. Patients in the residual group were generally older, more frequently suffered from hypertension and dyspnea, and had lower oxygen saturation and lymphocyte count, and lymphopenia was more prevalent among them. Moreover, patients in the residual group had higher initial lung involvement score, and the presence of lymphadenopathy and consolidation was more frequent among them. After adjustment for age, gender, and intervals between the two imagings, logistic regression results showed that hospitalization period, dyspnea, decreased oxygen saturation, decreased lymphocyte count, lymphopenia, consolidation, lymphadenopathy, and high initial lung involvement were strongly associated with the presence of long‑term abnormalities. Conclusion: The current study revealed multiple discrepancies between residual and nonresidual groups, which can be used to better identify the patients at risk of long‑term COVID‑19 lung complications.http://iahsj.kaums.ac.ir/article_176536_5661cb3311046a587b3c3e3d3f6732f4.pdfcovid-19computed tomographyfollow-up |
spellingShingle | Bahareh Safikhani Soheil Rahmani Fard Leyla Bahadorizadeh Fatemeh Shakki Katouli Yousef Alimohamadi Sara Minaeian Post-COVID-19 chest imaging evaluation: which patients should be prioritized for follow-up pulmonary assessment? International Archives of Health Sciences covid-19 computed tomography follow-up |
title | Post-COVID-19 chest imaging evaluation: which patients should be prioritized for follow-up pulmonary assessment? |
title_full | Post-COVID-19 chest imaging evaluation: which patients should be prioritized for follow-up pulmonary assessment? |
title_fullStr | Post-COVID-19 chest imaging evaluation: which patients should be prioritized for follow-up pulmonary assessment? |
title_full_unstemmed | Post-COVID-19 chest imaging evaluation: which patients should be prioritized for follow-up pulmonary assessment? |
title_short | Post-COVID-19 chest imaging evaluation: which patients should be prioritized for follow-up pulmonary assessment? |
title_sort | post covid 19 chest imaging evaluation which patients should be prioritized for follow up pulmonary assessment |
topic | covid-19 computed tomography follow-up |
url | http://iahsj.kaums.ac.ir/article_176536_5661cb3311046a587b3c3e3d3f6732f4.pdf |
work_keys_str_mv | AT baharehsafikhani postcovid19chestimagingevaluationwhichpatientsshouldbeprioritizedforfollowuppulmonaryassessment AT soheilrahmanifard postcovid19chestimagingevaluationwhichpatientsshouldbeprioritizedforfollowuppulmonaryassessment AT leylabahadorizadeh postcovid19chestimagingevaluationwhichpatientsshouldbeprioritizedforfollowuppulmonaryassessment AT fatemehshakkikatouli postcovid19chestimagingevaluationwhichpatientsshouldbeprioritizedforfollowuppulmonaryassessment AT yousefalimohamadi postcovid19chestimagingevaluationwhichpatientsshouldbeprioritizedforfollowuppulmonaryassessment AT saraminaeian postcovid19chestimagingevaluationwhichpatientsshouldbeprioritizedforfollowuppulmonaryassessment |